MYH9 and Macrothrombocytopenia: Heterozygous variants in MYH9 are associated with autosomal dominant steroid-resistant glomerular disease with intrafamilial variability in kidney disease severity, but also nearly always extrarenal features, notably macrothrombocytopenia, leukocyte inclusions, and sometimes hearing loss and cataracts.